NFE2L2 and multiple sclerosis: Dimethyl fumarate (DMF) is an agonist of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the rapid and durable ability of DMF has been confirmed in clinical trials in patients with multiple sclerosis [12, 13].